News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant.
|Title||Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant.|
|Publication Type||Journal Article|
|Year of Publication||2004|
|Authors||Angstreich GR, Smith DB, Jones RJ|
|Journal||Current opinion in oncology|
|Date Published||2004 Mar|
This review considers recent developments in the treatment of chronic myeloid leukemia with attention to current data evaluating the relative roles of imatinib mesylate, interferon-alpha, and allogeneic blood or marrow transplantation. Additionally, the review discusses advances in the basic understanding of the mechanisms by which these three different therapies function against chronic myeloid leukemia.
|Alternate Journal||Curr Opin Oncol|